Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 8;4(5):317-328.
doi: 10.1016/j.hroo.2023.03.001. eCollection 2023 May.

A randomized controlled trial of pulsed field ablation versus standard-of-care ablation for paroxysmal atrial fibrillation: The ADVENT trial rationale and design

Vivek Y Reddy  1 , John W Lehmann  2 , Edward P Gerstenfeld  3 , Andrew S Mugglin  4 , Christopher W Schneider  5 , Anitha B Achyutha  5 , Moussa Mansour  6
Affiliations

A randomized controlled trial of pulsed field ablation versus standard-of-care ablation for paroxysmal atrial fibrillation: The ADVENT trial rationale and design

Vivek Y Reddy et al. Heart Rhythm O2. .

Abstract

Background: Pulmonary vein isolation (PVI) is an effective treatment for paroxysmal atrial fibrillation (PAF). However, potential complications can occur due to the propagation of thermal energy into nontarget tissues adjacent to the targeted myocardium. Pulsed field ablation (PFA) is a novel ablation modality with the potential for preferential myocardial tissue ablation to minimize damage to collateral cardiac structures. A multielectrode pentaspline catheter has demonstrated safety and efficacy in treating PAF in single-arm, first-in-human studies.

Objective: The study sought to perform a randomized clinical trial to directly compare this PFA catheter with conventional ablation-either radiofrequency or cryoballoon ablation.

Methods: The ADVENT (Randomized Controlled Trial for Pulsed Field Ablation versus Standard of Care Ablation for Paroxysmal Atrial Fibrillation) trial is a multicenter, prospective, single-blind, randomized controlled trial to compare PVI using PFA vs conventional thermal ablation for drug-resistant PAF-with each site employing either (but not both) cryoballoon or radiofrequency ablation as a control condition. The sample size is adaptively determined based on Bayesian statistical methods. All patients will undergo PVI, and be followed for 12 months.

Results: The primary effectiveness endpoint is a composite of acute procedural success and freedom from any documented atrial arrhythmia recurrence, repeat ablation, or use of antiarrhythmic drugs after a 3-month postablation blanking period. The primary safety endpoint is a composite of defined acute and chronic device- and procedure-related serious adverse events. Both primary endpoints will be evaluated for noninferiority of the novel PFA system compared with standard-of-care thermal ablation.

Conclusions: By providing objective, comparative data, this study aims to scientifically determine whether the pentaspline PFA catheter is safe and effective for PVI ablation to treat drug-resistant PAF.

Keywords: Atrial fibrillation; Catheter ablation; Pulmonary vein isolation; Pulsed field ablation; Randomized controlled trial.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study flow diagram. CBA = cryoballoon ablation; PFA = pulsed field ablation; PVI = pulmonary vein isolation; RFA = radiofrequency ablation.
Figure 2
Figure 2
Pentaspline pulsed field ablation catheter.
Figure 3
Figure 3
Adaptive sample size determination algorithm.
See this image and copyright information in PMC

References

    1. Koruth J.S., Kuroki K., Iwasawa J., et al. Endocardial ventricular pulsed field ablation: a proof-of-concept preclinical evaluation. Europace. 2020;22:434–439. - PMC - PubMed
    1. Koruth J.S., Kuroki K., Kawamura I., et al. Pulsed field ablation versus radiofrequency ablation: esophageal injury in a novel porcine model. Circ Arrhythm Electrophysiol. 2020;13 - PMC - PubMed
    1. Reddy V.Y., Dukkipati S.R., Neuzil P., et al. Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II. J Am Coll Cardiol EP. 2021;7:614–627. - PubMed
    1. Cochet H., Nakatani Y., Sridi-Cheniti S., et al. Pulsed field ablation selectively spares the oesophagus during pulmonary vein isolation for atrial fibrillation. Europace. 2021;23:1391–1399. - PMC - PubMed
    1. Kotnik T., Rems L., Tarek M., Miklavcic D. Membrane electroporation and electropermeabilization: mechanisms and models. Annu Rev Biophys. 2019;48:63–91. - PubMed

LinkOut - more resources